AIA
RDY icon

Angeles Investment Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Angeles Investment Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,597
Closed -$294K – 160
2024
Q4 		$294K Sell
18,597
-2,483
-12% -$37.3K 0.01% 143
2024
Q3 		$335K Hold
21,080
– – 0.02% 154
2024
Q2 		$321K Buy
21,080
+4,500
+27% +$64.5K 0.02% 157
2024
Q1 		$243K Buy
+16,580
New +$242K 0.01% 188

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Angeles Investment Advisors's RDY Position: Q1 2025 in Review

Angeles Investment Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q1 2025, closing a stake of 18,597 shares — an estimated $294K sold.

Angeles Investment Advisors first reported a position in RDY in Q1 2024 and held it in 4 quarters. The position peaked at $335K in Q3 2024. 244 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

  • Angeles Investment Advisors reported no remaining Dr. Reddy's Laboratories position as of Q1 2025 after selling out during the quarter.
  • Angeles Investment Advisors sold 18,597 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $294K.
  • Angeles Investment Advisors first reported a position in Dr. Reddy's Laboratories in Q1 2024 and held it in 4 quarters.
  • Angeles Investment Advisors's Dr. Reddy's Laboratories position peaked at $335K in Q3 2024.
  • 244 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on Angeles Investment Advisors's 13F filing for Q1 2025, filed 15 May 2025.